US Pharma MarketingTanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.
Leo Pharma buys rare skin disease drug in $435M deal
Tanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.
Source: BioPharma Dive